Literature DB >> 3023105

GABA mechanisms of ventromedial thalamic nucleus in morphine-induced muscle rigidity.

K Ossowska, J Wardas, D Warchał, W Kolasiewicz, S Wolfarth.   

Abstract

The aim of the study was to investigate the role of the ventromedial thalamic nucleus in the rigidity induced by morphine. Muscle rigidity was assessed using an electromyographic method (EMG) in non-anaesthesized rats with electrodes implanted unilaterally in the gastrocnemius soleus muscle. Subcutaneous (s.c.) injections of morphine in doses of 5, 10 or 20 mg/kg evoked tonic EMG activity in the gastrocnemius soleus muscle; this was estimated as muscle rigidity. Picrotoxin was injected bilaterally into the ventromedial nucleus in doses of 50-400 ng/0.5 microliter 30 min after morphine administration. Picrotoxin in doses of 200 and 400 ng attenuated the tonic EMG activity induced by morphine, 10 mg/kg s.c. Picrotoxin in a dose of 400 ng reduced the tonic activity induced by morphine, 20 mg/kg s.c. The results suggest that the thalamic ventromedial nucleus mediates the morphine-induced rigidity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023105     DOI: 10.1016/0014-2999(86)90434-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Mechanographic analysis of muscle rigidity after morphine and haloperidol: a new methodological approach.

Authors:  W Kolasiewicz; J Baran; S Wolfarth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

2.  Haloperidol-increased muscle tone in rats as a model of parkinsonian rigidity.

Authors:  E Lorenc-Koci; S Wolfarth; K Ossowska
Journal:  Exp Brain Res       Date:  1996-05       Impact factor: 1.972

3.  Medial Parabrachial Nucleus Is Essential in Controlling Wakefulness in Rats.

Authors:  Qi Xu; Dian-Ru Wang; Hui Dong; Li Chen; Jun Lu; Michael Lazarus; Yoan Cherasse; Gui-Hai Chen; Wei-Min Qu; Zhi-Li Huang
Journal:  Front Neurosci       Date:  2021-03-25       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.